Gelonghui March 25 | Illumina, Inc. announced a reorganization of its board of directors, with Dr. Scott Gottlieb being appointed as the non-executive chairman of the board. Additionally, Keith Meister, founder, managing partner, and chief investment officer of Corvex Management, will join the board, effective March 28, 2025. According to a regulatory filing, Corvex Management holds approximately 1.7 million shares of Illumina stock. Keith Meister stated: "I look forward to collaborating with Illumina's board and strong management team. Illumina has the right strategy to expand its role in shaping the genomics field and broaden the application of these technologies in patient care. I am confident in Illumina’s ability to accelerate revenue growth and create value for shareholders."